Rapid manufacture of low-seed CAR-T cells in a GMP-grade hollow-fiber bioreactor platformStuart L. Gibb(University of California, San Francisco)CytotherapyNovember 8, 202410.1016/j.jcyt.2024.11.003Cited by 5SaveCiteExport RISWatch citationsRelated PapersTIMP3 Attenuates the Loss of Neural Stem Cells, Mature Neurons and Neurocognitive Dysfunction in Traumatic Brain Injury|Stem Cells|2015|50